American Journal of Epidemiology Original Contribution Circulating 25-hydroxyvitamin D and Risk of Endometrial Cancer Cohort Consortium Vitamin D Pooling Project of Rarer Cancers

A nested case-control study, including 830 cases and 992 controls from 7 cohorts, was conducted to evaluate the association of circulating 25-hydroxyvitamin D (25(OH)D), the best indicator of vitamin D status, with risk of endometrial cancer. Matching factors included age at blood donation, date of blood donation, and race. Conditional logistic regression was used in the main analysis. The median concentration of 25(OH)D was slightly lower in cases (49.4 nmol/L) than in controls (50.8 nmol/L) (P = 0.08). However, there was no association between 25(OH)D concentration and disease risk, after adjustment for body mass index. Compared with the 50–<75 nmol/L 25(OH)D category, the body mass index-adjusted odds ratios and 95% confidence intervals were 1.08 (95% confidence interval: 0.73, 1.57) for the <25 nmol/L category and 0.90 (95% confidence interval: 0.51, 1.58) for the ≥100 nmol/L category (Ptrend = 0.99). Similarly null results were observed after further adjustment for other known risk factors and in stratified analyses. Although an effect of circulating 25(OH)D at high concentrations cannot be ruled out (the highest category of 25(OH)D was ≥100 nmol/L, and for stratified analyses, ≥75 nmol/L), these results do not support a protective role of vitamin D against endometrial cancer.

[1]  R. Hayes,et al.  Circulating 25-Hydroxyvitamin D and the Risk of Rarer Cancers: Design and Methods of the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers , 2010, American journal of epidemiology.

[2]  R. Hayes,et al.  Cohort Consortium Vitamin D Pooling Project of Rarer Cancers , 2010 .

[3]  H. Hanwell,et al.  An evaluation of automated methods for measurement of serum 25-hydroxyvitamin D. , 2009, Clinical biochemistry.

[4]  M. Thun,et al.  Comparing methods for accounting for seasonal variability in a biomarker when only a single sample is available: insights from simulations based on serum 25-hydroxyvitamin d. , 2009, American journal of epidemiology.

[5]  A. Norman.  A vitamin D nutritional cornucopia: new insights concerning the serum 25-hydroxyvitamin D status of the US population. , 2008, The American journal of clinical nutrition.

[6]  Elizabeth A Yetley,et al.  Serum 25-hydroxyvitamin D status of the US population: 1988-1994 compared with 2000-2004. , 2008, The American journal of clinical nutrition.

[7]  M. McCullough,et al.  Vitamin D and calcium intake in relation to risk of endometrial cancer: a systematic review of the literature. , 2008, Preventive medicine.

[8]  V. Beral,et al.  Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study , 2007, BMJ : British Medical Journal.

[9]  S. Mohr,et al.  Is ultraviolet B irradiance inversely associated with incidence rates of endometrial cancer: an ecological study of 107 countries. , 2007, Preventive medicine.

[10]  L. Brinton,et al.  Endometrial cancer and menopausal hormone therapy in the National Institutes of Health‐AARP Diet and Health Study cohort , 2007, Cancer.

[11]  M. Friedrich,et al.  Expression of 25 hydroxyvitamin D3-1α-hydroxylase in human endometrial tissue , 2007, The Journal of Steroid Biochemistry and Molecular Biology.

[12]  P. Viganò,et al.  Cycling and early pregnant endometrium as a site of regulated expression of the vitamin D system. , 2006, Journal of molecular endocrinology.

[13]  E. Lazcano-Ponce,et al.  Dietary factors and endometrial cancer risk. Results of a case–control study in Mexico , 2005, International Journal of Gynecologic Cancer.

[14]  A. Uitterlinden,et al.  CHAPTER 68 – Genetic Vitamin D Receptor Polymorphisms and Risk of Disease , 2005 .

[15]  Patrick Neven,et al.  Endometrial cancer. , 2005, Lancet.

[16]  D. Rao,et al.  Analytical and clinical validation of the 25 OH vitamin D assay for the LIAISON automated analyzer. , 2004, Clinical biochemistry.

[17]  S. Miettinen,et al.  Expression of Nuclear Receptors and Cofacotrs in Human Endometrium and Myometrium , 2004, The Journal of the Society for Gynecologic Investigation: JSGI.

[18]  O. Miettinen,et al.  Endometrial cancer risk after discontinuing use of unopposed conjugated estrogens (California, United States) , 1995, Cancer Causes & Control.

[19]  C. M. Hansen,et al.  Mechanisms implicated in the growth regulatory effects of vitamin D compounds in breast cancer cells. , 2003, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[20]  J. Welsh,et al.  Impact of the Vitamin D3 receptor on growth-regulatory pathways in mammary gland and breast cancer , 2002, The Journal of Steroid Biochemistry and Molecular Biology.

[21]  T. Key,et al.  Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. , 2002, Journal of the National Cancer Institute.

[22]  W. Grant.  An estimate of premature cancer mortality in the U.S. due to inadequate doses of solar ultraviolet‐B radiation , 2002, Cancer.

[23]  C. Hansen,et al.  Mechanisms implicated in the growth regulatory effects of vitamin D in breast cancer. , 2002, Endocrine-related cancer.

[24]  M. Holick,et al.  Decreased bioavailability of vitamin D in obesity. , 2000, The American journal of clinical nutrition.

[25]  C. la Vecchia,et al.  Intake of selected micronutrients and the risk of endometrial carcinoma , 1996, Cancer.

[26]  J. Manson,et al.  Reproducibility of plasma hormone levels in postmenopausal women over a 2-3-year period. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[27]  P. Strax,et al.  Reliability of measurements of total, protein-bound, and unbound estradiol in serum. , 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[28]  E. Partridge,et al.  Diet and endometrial cancer: a case-control study. , 1993, American journal of epidemiology.

[29]  Gerhard Jentzsch,et al.  Working group on , 1991 .

[30]  M. Holick,et al.  An evaluation of the relative contributions of exposure to sunlight and of diet to the circulating concentrations of 25-hydroxyvitamin D in an elderly nursing home population in Boston. , 1990, The American journal of clinical nutrition.

[31]  M. Pike,et al.  The dose-effect relationship between 'unopposed' oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk. , 1988, British Journal of Cancer.

[32]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[33]  R. Wallace,et al.  Parameters related to 25-OH-D levels in a population-based study of women. , 1986, The American journal of clinical nutrition.

[34]  T. Oppé,et al.  Vitamin D deficiency. , 1979, British medical journal.

[35]  J. Ferlay,et al.  Cancer Incidence in Five Continents , 1970, Union Internationale Contre Le Cancer / International Union against Cancer.